Skip to main content
. 2018 Jan 3;26(3):416–421. doi: 10.1016/j.jsps.2017.12.020

Table 5.

Association between CAM Use and Quality of Life EORTC QLQ-C30.

CAM Users Non-CAM Users
EORTC QLQ-C30 Mean ± SD Mean ± SD P-value
Global health status QoL 73.16 ± 20.26 64.82 ± 32.79 0.049**
Functional Scale
Physical 68.05 ± 21.72 63.33 ± 28.02 0.055**
Role 78.14 ± 29.28 62.96 ± 42.23 0.002**
Emotional 70.78 ± 29.54 67.14 ± 32.39 0.733
Cognitive 79.22 ± 24.05 83.33 ± 25.56 0.934
Social 83.33 ± 26.35 72.22 ± 33.82 0.047**
Symptom Scale
Fatigue 33.62 ± 29.13 41.97 ± 30.39 0.729
Nausea & Vomiting 19.70 ± 30.55 12.04 ± 26.07 0.200
Pain 33.99 ± 31.46 50.92 ± 28.85 0.424
Dyspnea 25.11 ± 30.19 24.07 ± 29.83 0.614
Insomnia 48.06 ± 41.01 40.74 ± 46.52 0.249
Appetite Loss 31.60 ± 34.59 29.63 ± 41.05 0.151
Constipation 29.01 ± 39.13 14.81 ± 28.52 0.005**
Diarrhea 12.99 ± 28.69 18.52 ± 38.30 0.133
Financial difficulties 13.42 ± 29.25 20.37 ± 34.56 0.264

Note: Based on 95 Women, 18 years and above with breast cancer.

EORTC QLQ-C30: The generic European Organization for Research and Treatment of Cancer questionnaire, SD: Standard Deviation, CAM: Complementary Alternative Medicine.